Icomb 10 Mg/10 Mg Capsule Rigide

Ramipril and amlodipine besilate, the active ingredients in Icomb 10 Mg/10 Mg Capsule Rigide, are an ACE inhibitor and a calcium‑channel blocker presented as a 10 mg/10 mg hard capsule for oral use. They treat hypertension in adult patients. GNH USA supplies Icomb 10 Mg/10 Mg Capsule Rigide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Icomb combines ramipril and amlodipine besilate, an ACE‑inhibitor and calcium‑channel blocker, to manage high blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure in adults. - Essential hypertension: provides sustained blood‑pressure control when monotherapy is insufficient. - Isolated systolic hypertension: reduces elevated systolic pressure in elderly patients.

Icomb may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Cough: persistent dry cough. - Dizziness: especially upon standing. - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Flushing: transient warmth and redness. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat. - Severe hypotension: marked drop in blood pressure after first dose. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Neutropenia: low white‑blood‑cell count. - Anaphylactic reaction: severe allergic response requiring emergency care.

Before initiating therapy, consider the following safety measures.

- Monitor blood pressure: ensure target levels are achieved without excessive drop. - Assess renal function: check creatinine and eGFR periodically. - Check electrolytes: especially potassium when combined with diuretics. - Avoid in pregnancy: category D, discontinue if pregnancy occurs. - Use cautiously in elderly: start at lower dose and monitor for orthostatic hypotension. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Icomb can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Aliskiren in diabetic patients: risk of renal impairment and hyperkalemia. - Potassium‑sparing diuretics: may cause dangerous hyperkalemia. - Strong CYP3A4 inhibitors (e.g., itraconazole): increase amlodipine plasma levels. - NSAIDs combined with ACE inhibitor: heightened risk of renal dysfunction. - Other antihypertensives: may lead to excessive hypotension.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: additive blood‑pressure lowering effect. - Lithium: possible increase in lithium concentrations. - CYP3A4 inducers (e.g., rifampicin): may reduce amlodipine efficacy. - Antidiabetic agents: blood‑glucose control may improve, requiring dose adjustment. - NSAIDs alone: may blunt antihypertensive response.